Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v3-FR Version v3-FR
Language French French
Date Updated 2024-10-29 2024-10-29
Drug Identification Number 02306727 02306727
Brand name PANTOPRAZOLE SODIUM FOR INJECTION PANTOPRAZOLE SODIUM FOR INJECTION
Common or Proper name PANTOPRAZOLE SODIUM FOR INJECTION PANTOPRAZOLE SODIUM FOR INJECTION
Company Name SANDOZ CANADA INCORPORATED SANDOZ CANADA INCORPORATED
Ingredients PANTOPRAZOLE PANTOPRAZOLE
Strength(s) 40MG 40MG
Dosage form(s) POWDER FOR SOLUTION POWDER FOR SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS INTRAVENOUS INTRAVENOUS
Packaging size 10LYVI 10LYVI
ATC code A02BC A02BC
ATC description DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD) DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)
Reason for discontinuation Manufacturing issues Manufacturing issues
Anticipated discontinuation date
Actual discontinuation date 2024-10-28 2024-10-28
Remaining supply date
Discontinuation status Discontinued Discontinued
Discontinuation decision reversal no no
Tier 3 Status No No
Information on remaining supply
Company comments
Health Canada comments